On the recordSeptember 18, 2014
GAIN did not fully fix the problem, and much more is needed if we are to incentivize the type of drug development needed to combat this global threat.
Source
congress.govJoe Pitts: “GAIN did not fully fix the problem, and much more is needed if we are to incentivize the type of drug development needed…”
Editor's note · Context
Pitts acknowledges that further action is necessary beyond the GAIN Act to address antibiotic resistance.
Share
More from Joe Pitts
Dec 6, 2016
Explicitly creating a program exclusively for catfish seems to be unnecessary, and it directs resources away from high-risk foods.
Dec 6, 2016
Both the FDA and the General Accountability Office agree that there is no food safety justification for this regulatory divide.
Other voices in this conversation
